Please login to the form below
Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance treatment and improve patient and stakeholder outcomes.
For many years the industry has promised to democratise healthcare through the invention of digital tools, which enable holistic care.
These services are designed to improve the customer experience. When designed well, they use data and analytics to facilitate better decision-making in the clinic and uncover deeper insights that can result in R&D breakthroughs. However, several barriers are preventing the potential of these tools from being realised.
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance treatment and improve patient and stakeholder outcomes.
Download the magazine to learn:
- Why aren’t doctor’s using digital therapeutics?
- Digital therapeutics and their impact on society
- Designing a global digital patient services platform
- How we should be rethinking electronic medical records
- Digital nation: how Australia became digital health pioneers
- The intelligent pill replacing insulin injections
- How to enhance the lifecycle of your insight
If you would like to find out more about how we can help your brand to reach and engage with your customers in innovative ways, please get in touch with simon.young@bluelatitude.com
DOWNLOAD THE FULL PUBLICATION HERE
Company Details
Blue Latitude Health
Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom
Latest content on this profile
- Three strategies for managing loss of exclusivity successfully
- Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
- What does the future hold for Medical Affairs?
- Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
- Unpacking rare diseases in the first edition of Delta magazine
- Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health
